Dr. Yi Xia 夏奕
Chief Physician
Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Chemotherapy and targeted therapy for lymphoma and head and neck tumors.
Dr. Xia is a Chief Physician and doctoral supervisor at Sun Yat-sen University Cancer Center. Dr. Xia earned a medical degree from Sun Yat-sen University of Medical Sciences in 2000 and a PhD in Oncology from Sun Yat-sen University in 2009. Since 2000, Dr. Xia has worked in the Department of Medical Oncology, focusing on clinical treatment and research for lymphoma and head and neck tumors.
Professional roles
- Standing Committee Member, Guangdong Provincial Youth Committee on Tumor Targeted and Individualized Therapy
- Standing Committee Member, Lymphoma Professional Committee, Guangdong Female Physicians Association
Name order: in Chinese the family name comes first (Xia Yi). Papers usually list the name as Yi Xia or Xia Y.
Selected publications
79 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- Neurooncol Adv, 2026 (senior author): Improved efficacy of orelabrutinib plus rituximab, temozolomide and high-dose methotrexate versus rituximab, high-dose methotrexate plus temozolomide in untreated primary CNS lymphoma: A matched analysis. PubMed 42948599
- Ann Hematol, 2025 (senior author): Efficacy of radiotherapy in primary mediastinal diffuse large B-cell lymphoma: a systematic review and meta-analysis of 1,392 patients. PubMed 40993400
- Adv Sci (Weinh), 2025 (senior author): Tumor-Associated Sympathetic Nerves Promote the Progression of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma. PubMed 40488319
- BMC Med, 2025 (senior author): Nimotuzumab combined with docetaxel and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: a multicenter, phase 2 trial. PubMed 40325445
- Cancers (Basel), 2021 (first author): Prognostication of Primary Tumor Location in Early-Stage Nodal Diffuse Large B-Cell Lymphoma: An Analysis of the SEER Database. PubMed 34439110
- Cancer Res Treat, 2019 (senior author): Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience. PubMed 30971067
- Cancer Med, 2019 (senior author): Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis. PubMed 30706675
- Dis Markers, 2018 (senior author): The Clinical Utility of Circulating Epstein-Barr Virus DNA Concentrations in NK/T-Cell Lymphoma: A Meta-Analysis. PubMed 30581497
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion